Type
1.
Sousa J, Aarão TLS, Rodrigues de Sousa J, Hirai KE, Mota Silva L, Dias LB, et al. Endothelium adhesion molecules ICAM-1, ICAM-2, VCAM-1 and VLA-4 expression in leprosy. Microbial pathogenesis. 2017;
Type
1.
Ura S, Baccarelli R, Marciano L, Teixeira MJ, Virmond M, Raicher I, et al. Neuropathic pain in leprosy: symptom profile characterization and comparison with neuropathic pain of other etiologies. PAIN Reports [Internet]. 2018;:1-7. Available from: https://journals.lww.com/painrpts/Fulltext/2018/04000/Neuropathic_pain_in_leprosy___symptom_profile.4.aspx
Type
1.
CBJM C. Reducing Stigmatisation of Leprosy: What is Being Done? Journal of traditional medicine & clinical naturopathy [Internet]. 2016;(5):194. Available from: https://www.omicsgroup.org/journals/reducing-stigmatisation-of-leprosy-what-is-being-done-.php?aid=81344
Type
1.
Binns C, Low WY. Leprosy. Asia-Pacific journal of public health [Internet]. 2016;28(7):560-1. Available from: http://journals.sagepub.com/doi/pdf/10.1177/1010539516671035
Type
1.
Jindal A, Prabhu S, Shenoi S, Pai K, Nayak S. Conjugal leprosy: is there a need for active surveillance in endemic areas? Tropical doctor [Internet]. 2017;:49475516686541. Available from: http://journals.sagepub.com/doi/pdf/10.1177/0049475516686541
Type
1.
Kolay SK, Bisai S, Pal R, Mohanta PK, Sarbapalli D. Knowledge, attitude and stigma experienced by leprosypatients in tribalconcentrated Bastar district of Chhattisgarh, India. Turkish Journal of Public Health [Internet]. 2016;14(3):178–187. Available from: http://www.tjph.org/ojs/index.php/TJPH/article/view/568
Type
1.
Aguilar-Medina M, Escamilla-Tilch M, Frías-Castro LO, Romero-Quintana G, Estrada-Garcia I, Estrada-Parra S, et al. HLA Alleles are Genetic Markers for Susceptibility and Resistance towards Leprosy in a Mexican Mestizo Population. Annals of human genetics. 2016;
Type
1.
Siwakoti S, Rai K, Bhattarai NR, Agarwal S, Khanal B. Evaluation of Polymerase Chain Reaction (PCR) with Slit Skin Smear Examination (SSS) to Confirm Clinical Diagnosis of Leprosy in Eastern Nepal. PLoS neglected tropical diseases [Internet]. 2016;10(12):e0005220. Available from: http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0005220
Type
1.
Tarique M, Saini C, Naqvi RA, Khanna N, Rao. Increased IL-35 producing Tregs and CD19(+)IL-35(+) cells are associated with disease progression in leprosy patients. Cytokine. 2016;91:82-8.
Type
1.
Kumbar R, Dravid N, Nagappa KG, Rokade C. Infectious Granulomatous Dermatitis at a Tertiary Care Centre in North Maharashtra: A Histopathological Study. Journal of clinical and diagnostic research : JCDR [Internet]. 2016;10(11):EC13-EC16. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198327/pdf/jcdr-10-EC13.pdf
Pagination
- Previous page
- Page 231
- Next page